Your chances of a migraine increase with hotter temperatures
Research by Dr. Vincent Martin is featured in national and international media
A change in weather is one of the most common trigger factors for migraine. Hotter temperatures increase the chance of a migraine attack, according to research led by Vincent Martin, MD, director of the Headache and Facial Pain Center at UC’s Gardner Neuroscience Institute.
Martin, also a professor in the UC College of Medicine, spoke with Cincinnati’s Fox 19 News about his latest study findings which looked at use of Fremanezumab and whether it could prevent headaches caused by temperature increases. Produced by Teva Pharmaceuticals USA, Fremanezumab is sold under the brand name AJOVY®, administered by injection under the skin to treat migraines.
A research team led by Martin cross-referenced 71,030 daily diary records of 660 migraine patients with regional weather data and found that for every temperature increase of 10 degrees Fahrenheit daily, there was a 6% increase in occurrence of any headache. However, during the time periods of Fremanezumab treatment the association completely disappeared.
Record high temperatures across much of the Midwest and Northeast regions of the country has increased dialogue about health ailments associated with the heat. Martin’s findings were reported on more than 200 media outlets including CBS News, The Atlanta Journal Constitution, The Miami Herald and internationally in publications such as Greece’s Tempo 24, Argentina’s Infobae, Italy’s Agenzia Italia, Mexico’s El Cuarto Poder , Venezuela’s Noticias Venevision and Indonesia’s Suara Merdeka.
Read about the research findings from Vincent Martin, MD, online.
Learn more about migraines and hotter temperatures on CBS News
Featured top image is courtesy of Istock.
Related Stories
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.
Cincinnati takes the lead in health care innovation
December 3, 2025
Health care innovation shone at the 1819 Venture Lab’s Demo Day, which showcased products that could revolutionize patient care and improve treatment experiences.
UC Cancer Center launches Rapid Access Program for lung cancer patients
December 3, 2025
Spectrum News highlighted a new University of Cincinnati Cancer Center Rapid Access Program to streamline care for patients with lung cancer.